Utilizing Nanotechnology for Targeted Drug Delivery in Cancer Treatment

Thesis Abstract

Abstract
Targeted drug delivery using nanotechnology has emerged as a promising approach in cancer treatment, offering the potential for improved therapeutic efficacy and reduced side effects. This thesis explores the application of nanotechnology in delivering anticancer drugs specifically to tumor sites while sparing healthy tissues. The research investigates the various nanocarriers and targeting strategies employed in cancer therapy, highlighting their advantages and challenges. The study also examines the mechanisms of action of nanomedicines in cancer treatment, emphasizing the importance of precise drug delivery to enhance therapeutic outcomes. Chapter one provides an introduction to the research area, presenting the background, problem statement, objectives, limitations, scope, significance, structure of the thesis, and definition of key terms. The literature review in chapter two critically analyzes existing studies on nanotechnology-based drug delivery systems for cancer treatment, discussing key findings and gaps in current knowledge. Chapter three outlines the research methodology, including the selection of nanocarriers, drug loading techniques, in vitro and in vivo evaluation methods, and data analysis procedures. Chapter four presents a detailed discussion of the research findings, focusing on the efficacy and safety of nanotechnology-based drug delivery in targeting cancer cells. The chapter also explores the factors influencing the performance of nanocarriers, such as size, surface properties, and drug release kinetics. The conclusion in chapter five summarizes the key findings of the study, highlighting the potential of nanotechnology for targeted drug delivery in cancer treatment and discussing future research directions. Overall, this thesis contributes to the growing body of knowledge on the use of nanotechnology in cancer therapy, offering insights into the design and optimization of nanocarriers for enhanced drug delivery efficiency. The findings of this research have implications for the development of novel and effective cancer treatments that can improve patient outcomes and quality of life.